| Similar Articles |
|---|
 |
Nurse Practitioner
December 2009
Gujral & Collantes |
Understanding Viral Hepatitis: A guide for primary care Recent advancements in the field of genomics and proteomics technology have given researchers and clinicians more insight on disease pathogenesis and helped create more tailored approaches to the treatment of these conditions.   |
Nurse Practitioner
July 2010
Christine S. Brennan |
Overcoming barriers to new treatment options for hepatitis C This article reviews current guidelines for HCV treatment and proposes strategies to overcome potential barriers to state-of-the-art therapy. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing
March 2012
Daniel A. Hussar |
New Drugs 2012: part I In this article, you'll learn about 11 recently approved drugs. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Nurse Practitioner
February 2011
Jennifer M. Belavic |
Annual Drug Update: 2010 in Review In 2010, the FDA approved several new drugs and new indications for use in primary care. From new therapies for adults with rheumatoid arthritis to a combination drug for benign prostatic hyperplasia, NPs need to be aware of the latest medications now available. |
American Family Physician
June 1, 2006
Bayard, Holt & Boroughs |
Nonalcoholic Fatty Liver Disease Nonalcoholic fatty liver disease is a common condition associated with metabolic syndrome. It is the most common cause of elevated liver enzymes in U.S. adults, and is diagnosed after ruling out other causes of steatosis, particularly infectious hepatitis and alcohol abuse. |
American Family Physician
November 1, 2001
Thomas R. Riley |
Preventive Strategies in Chronic Liver Disease Chronic liver disease is the 10th leading cause of death in the United States. Preventive care can significantly reduce the progression of liver disease. Part I: Alcohol, Vaccines, Toxic Medications and Supplements, Diet and Exercise... |
American Family Physician
March 15, 2005
Paul T. Giboney |
Mildly Elevated Liver Transaminase Levels in the Asymptomatic Patient Mild elevations in liver chemistry tests can reveal serious underlying conditions or have transient and benign etiologies. If elevations persist after an appropriate period of observation, further testing may include ultrasonography and other serum studies. |
Nursing
February 2009
Daniel A. Hussar |
New Drugs 09: Part 1 Learn about 10 new drugs, including nebivolol HCl, the newest beta-adrenergic blocking agent for hypertension. |
The Motley Fool
September 7, 2010
Luke Timmerman |
Vertex Nails Third Big Trial With Hepatitis C Drug And in the toughest patients to treat, too. |
American Journal of Nursing
February 2010
Melissa M. Smith |
Emergency: Variceal Hemorrhage from Esophageal Varices Associated with Alcoholic Liver Disease This article describes alcoholic cirrhosis and its complications, discusses the etiology of esophageal varices and the risk factors for hemorrhage, and addresses emergent treatment. |
American Family Physician
September 1, 2006
Heidelbaugh & Bruderly |
Cirrhosis and Chronic Liver Failure: Part I. Diagnosis and Evaluation Part I of a two-part on how to diagnose and determine treatment for cirrhosis and chronic liver failure. |
The Motley Fool
August 10, 2010
Ryan McBride |
Vertex's Telaprevir Clears Hurdle, Could Halve Treatment Times for Hepatitis C Study results are positive. |
American Family Physician
January 15, 2004
Roche & Kobos |
Jaundice in the Adult Patient Jaundice in an adult patient can be caused by a wide variety of benign or life-threatening disorders. Organizing the differential diagnosis by prehepatic, intrahepatic, and posthepatic causes may help make the work-up more manageable. |
American Family Physician
November 15, 2001
Thomas R. Riley |
Preventive Strategies in Chronic Liver Disease: Part II. Cirrhosis Cirrhosis is a diffuse process characterized by fibrosis and the conversion of normal liver architecture into structurally abnormal nodules. Strategies have been established to prevent complications in patients with cirrhosis... |
The Motley Fool
August 5, 2010
Brian Orelli |
Blockbuster Efficacy! Not-So-Blockbuster Safety! Isis and Genzyme's wonder drug has not-so-wonderful side effects. Still. |
HHMI Bulletin
Fall 2012
Sarah C. P. Williams |
The Fat You Can't See Without the liver acting as a filter and energy producer, a person can't survive, and no artificial organ can perform all of its duties. But in one in three Americans -- and similar numbers in other developed nations -- the liver has lost its luster. |
The Motley Fool
November 18, 2009
Brian Orelli |
Drug Lowers Cholesterol; Stock Follows ISIS has a hard time at American Heart Association despite good efficacy data. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
The Motley Fool
August 11, 2010
Brian Orelli |
Dang! This Drug Is Shining Brighter Vertex illuminates telaprevir's additional benefit in treating hepatitis C patients. |
The Motley Fool
February 11, 2010
Brian Orelli |
A Wonder Drug With Not-So-Wonderful Side Effects Wonder drug or not, Isis Pharmaceuticals and Genzyme's cholesterol drug mipomersen's sales will be limited by side effects. |
The Motley Fool
December 16, 2011
Brian Orelli |
Safety (Still) Trumps Acquisitions in Hep C Pharmasset announced it was discontinuing all treatment arms in one of its phase 2b trials that contain the drug PSI-938. The drug candidate caused laboratory abnormalities in tests associated with liver function. |
Chemistry World
September 11, 2013
Emma Stoye |
Call to overhaul liver toxicity testing Outdated assays for monitoring liver health could have caused dozens of drug candidates to be wrongly scrapped during development, according to new research. |
Nurse Practitioner
July 2008
Lynn A. Kelso |
Cirrhosis: Caring for Patients with End-stage Liver Failure Caring for patients with end-stage liver disease can be very challenging for NPs. |
American Family Physician
November 15, 2006
Mark H. Ebell |
Point-of-Care Guides The Model for End-Stage Liver Disease (MELD), United Network for Organ Sharing modification. |
American Family Physician
September 1, 2006 |
Cirrhosis and Chronic Liver Failure: What You Should Know The basics about cirrhosis and chronic liver failure. |
HHMI Bulletin
May 2010
Sarah C.P. Williams |
Lab-Grown Liver New cell culture system solves problem of growing liver cells. |
Food Processing
June 2013
Mark Anthony |
Many New Botanicals Being Explored For Their Potential In Helping To Maintain Gut Health As Americans pursue healthier versions of foods, new botanicals and new applications for old botanicals are continuously being explored. |
AskMen.com
Alex Santoso |
Liver Health: The Beer Drinker's Best Herbs Studies have suggested that, when consumed in moderation, beer has many health benefits. |
